September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 28, 2018 — At one year following transcatheter aortic valve replacement (TAVR), implantation with the Portico ...
September 28, 2018 — The first randomized study to compare general versus local anesthesia during transcatheter aortic ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...
September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus ...
Akshay Khandelwal, M.D., director of medical operations at the Henry Ford Heart and Vascular Institute, Detroit, and ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio ...
Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced ...
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018 ...
September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-upon ...
September 25, 2018 — Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early ...
September 24, 2018 — New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21 ...
September 24, 2018 — Corindus Vascular Robotics Inc. announced the first live transmission of a remote interventional ...
September 28, 2018